| Code Name |
|---|
| +MS – 20 Oncology |
| Pre-clinical | Phase I | Phase II | Phase III | NDA | On market |
|---|
| Code Name |
|---|
| +Herbiron Anemia |
| Pre-clinical | Phase I | Phase II | Phase III | NDA | On market |
|---|
Medical Device
| Name |
Indication | Route of Administration |
|---|---|---|
| MB107 |
Atopic Dermatitis |
Topical (skin application) |
| Pre-study |
Pre-clinical Research |
Exploratory Clinical Trial |
Medical Device Approval |
Market Launch |
|---|
| Name |
Indication | Route of Administration |
|---|---|---|
| MB107 |
Psoriasis |
Topical (skin application) |
| Pre-study |
Pre-clinical Research |
Exploratory Clinical Trial |
Medical Device Approval |
Market Launch |
|---|
| Name |
Indication | Route of Administration |
|---|---|---|
| MB828 |
Allergic Rhinitis |
Nasal Spray |
| Pre-study |
Pre-clinical Research |
Exploratory Clinical Trial |
Medical Device Approval |
Market Launch |
|---|
| Name |
Indication | Route of Administration |
|---|---|---|
| MB-V |
Vaginitis |
Vaginal Delivery |
| Pre-study |
Pre-clinical Research |
Exploratory Clinical Trial |
Medical Device Approval |
Market Launch |
|---|
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
